These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 22763381)

  • 1. Haplotype analysis of the 185delAG BRCA1 mutation in ethnically diverse populations.
    Laitman Y; Feng BJ; Zamir IM; Weitzel JN; Duncan P; Port D; Thirthagiri E; Teo SH; Evans G; Latif A; Newman WG; Gershoni-Baruch R; Zidan J; Shimon-Paluch S; Goldgar D; Friedman E
    Eur J Hum Genet; 2013 Feb; 21(2):212-6. PubMed ID: 22763381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 185delAG BRCA1 mutation originated before the dispersion of Jews in the diaspora and is not limited to Ashkenazim.
    Bar-Sade RB; Kruglikova A; Modan B; Gak E; Hirsh-Yechezkel G; Theodor L; Novikov I; Gershoni-Baruch R; Risel S; Papa MZ; Ben-Baruch G; Friedman E
    Hum Mol Genet; 1998 May; 7(5):801-5. PubMed ID: 9536083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women.
    Abeliovich D; Kaduri L; Lerer I; Weinberg N; Amir G; Sagi M; Zlotogora J; Heching N; Peretz T
    Am J Hum Genet; 1997 Mar; 60(3):505-14. PubMed ID: 9042909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 1100delAT BRCA1 and the 8765delAG BRCA2 mutations: occurrence in high-risk non-Ashkenazi Jews and haplotype comparison of Jewish and non-Jewish carriers.
    Gal I; Gershoni Baruch R; Haber D; Dagan E; Eisenberg-Barzilai S; Zidan J; Friedman E
    Fam Cancer; 2004; 3(1):11-4. PubMed ID: 15131400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Could the 185delAG BRCA1 mutation be an ancient Jewish mutation?
    Bar-Sade RB; Theodor L; Gak E; Kruglikova A; Hirsch-Yechezkel G; Modan B; Kuperstein G; Seligsohn U; Rechavi G; Friedman E
    Eur J Hum Genet; 1997; 5(6):413-6. PubMed ID: 9450187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haplotype analysis of a BRCA1: 185delAG mutation in a Chilean family supports its Ashkenazi origins.
    Ah Mew N; Hamel N; Galvez M; Al-Saffar M; Foulkes WD
    Clin Genet; 2002 Aug; 62(2):151-6. PubMed ID: 12220453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers.
    Im KM; Kirchhoff T; Wang X; Green T; Chow CY; Vijai J; Korn J; Gaudet MM; Fredericksen Z; Shane Pankratz V; Guiducci C; Crenshaw A; McGuffog L; Kartsonaki C; Morrison J; Healey S; Sinilnikova OM; Mai PL; Greene MH; Piedmonte M; Rubinstein WS; ; Hogervorst FB; Rookus MA; Collée JM; Hoogerbrugge N; van Asperen CJ; Meijers-Heijboer HE; Van Roozendaal CE; Caldes T; Perez-Segura P; Jakubowska A; Lubinski J; Huzarski T; Blecharz P; Nevanlinna H; Aittomäki K; Lazaro C; Blanco I; Barkardottir RB; Montagna M; D'Andrea E; ; Devilee P; Olopade OI; Neuhausen SL; Peissel B; Bonanni B; Peterlongo P; Singer CF; Rennert G; Lejbkowicz F; Andrulis IL; Glendon G; Ozcelik H; ; Toland AE; Caligo MA; ; Beattie MS; Chan S; ; Domchek SM; Nathanson KL; Rebbeck TR; Phelan C; Narod S; John EM; Hopper JL; Buys SS; Daly MB; Southey MC; Terry MB; Tung N; Hansen TV; Osorio A; Benitez J; Durán M; Weitzel JN; Garber J; Hamann U; ; Peock S; Cook M; Oliver CT; Frost D; Platte R; Evans DG; Eeles R; Izatt L; Paterson J; Brewer C; Hodgson S; Morrison PJ; Porteous M; Walker L; Rogers MT; Side LE; Godwin AK; Schmutzler RK; Wappenschmidt B; Laitman Y; Meindl A; Deissler H; Varon-Mateeva R; Preisler-Adams S; Kast K; Venat-Bouvet L; Stoppa-Lyonnet D; Chenevix-Trench G; Easton DF; Klein RJ; Daly MJ; Friedman E; Dean M; Clark AG; Altshuler DM; Antoniou AC; Couch FJ; Offit K; Gold B
    Hum Genet; 2011 Nov; 130(5):685-99. PubMed ID: 21597964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Tyr978X BRCA1 mutation: occurrence in non-Jewish Iranians and haplotype in French-Canadian and non-Ashkenazi Jews.
    Quintana-Murci L; Gal I; Bakhan T; Quach H; Sayar SH; Shiri-Sverdlov R; Baruch RG; McElreavey K; Dagan E; Narod S; Friedman E
    Fam Cancer; 2005; 4(2):85-8. PubMed ID: 15951957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The BRCA1 Ashkenazi founder mutations occur on common haplotypes and are not highly correlated with anonymous single nucleotide polymorphisms likely to be used in genome-wide case-control association studies.
    Pereira LH; Pineda MA; Rowe WH; Fonseca LR; Greene MH; Offit K; Ellis NA; Zhang J; Collins A; Struewing JP
    BMC Genet; 2007 Oct; 8():68. PubMed ID: 17916242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two distinct origins of a common BRCA1 mutation in breast-ovarian cancer families: a genetic study of 15 185delAG-mutation kindreds.
    Berman DB; Wagner-Costalas J; Schultz DC; Lynch HT; Daly M; Godwin AK
    Am J Hum Genet; 1996 Jun; 58(6):1166-76. PubMed ID: 8651293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An identical novel mutation in BRCA1 and a common haplotype in familial ovarian cancer in non-Ashkenazi Jews.
    Theodor L; Bar-Sade R; Kruglikova A; Ben-Baruch G; Risel S; Shiri-Sverdlov R; Hirsh Yechezkel G; Modan B; Papa MZ; Rechavi G; Friedman E
    Br J Cancer; 1998 Jun; 77(11):1880-3. PubMed ID: 9667663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent germline mutations in BRCA1 and BRCA2 genes in high risk families in Israel.
    Laitman Y; Simeonov M; Herskovitz L; Kushnir A; Shimon-Paluch S; Kaufman B; Zidan J; Friedman E
    Breast Cancer Res Treat; 2012 Jun; 133(3):1153-7. PubMed ID: 22399190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Founder mutations in BRCA1/2 are not frequent in Canadian Ashkenazi Jewish men with prostate cancer.
    Hamel N; Kotar K; Foulkes WD
    BMC Med Genet; 2003 Aug; 4():7. PubMed ID: 12911837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2.
    Roa BB; Boyd AA; Volcik K; Richards CS
    Nat Genet; 1996 Oct; 14(2):185-7. PubMed ID: 8841191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Tyr978X BRCA1 Mutation in Non-Ashkenazi Jews: Occurrence in High-Risk Families, General Population and Unselected Ovarian Cancer Patients.
    Shiri-Sverdlov R; Gershoni-Baruch R; Ichezkel-Hirsch G; Gotlieb WH; Bruchim Bar-Sade R; Chetrit A; Rizel S; Modan B; Friedman E
    Community Genet; 2001 Jul; 4(1):50-55. PubMed ID: 11493753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haplotype of the C61G BRCA1 mutation in Polish and Jewish individuals.
    Kaufman B; Laitman Y; Gronwald J; Lubinski J; Friedman E
    Genet Test Mol Biomarkers; 2009 Aug; 13(4):465-9. PubMed ID: 19594371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel inherited mutations and variable expressivity of BRCA1 alleles, including the founder mutation 185delAG in Ashkenazi Jewish families.
    Friedman LS; Szabo CI; Ostermeyer EA; Dowd P; Butler L; Park T; Lee MK; Goode EL; Rowell SE; King MC
    Am J Hum Genet; 1995 Dec; 57(6):1284-97. PubMed ID: 8533757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The I1307K APC polymorphism: prevalence in non-Ashkenazi Jews and evidence for a founder effect.
    Shtoyerman-Chen R; Friedman E; Figer A; Carmel M; Patael Y; Rath P; Fidder HH; Bar-Meir S; Theodor L
    Genet Test; 2001; 5(2):141-6. PubMed ID: 11551102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.
    Satagopan JM; Boyd J; Kauff ND; Robson M; Scheuer L; Narod S; Offit K
    Clin Cancer Res; 2002 Dec; 8(12):3776-81. PubMed ID: 12473589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A low frequency of non-founder BRCA1 mutations in Ashkenazi Jewish breast-ovarian cancer families.
    Phelan CM; Kwan E; Jack E; Li S; Morgan C; Aubé J; Hanna D; Narod SA
    Hum Mutat; 2002 Nov; 20(5):352-7. PubMed ID: 12402332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.